Patent ID: 11931408
Assignee: BAYLOR COLLEGE OF MEDICINE
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  G  Y | IPC A  G

Claim 0:
1. A composition comprising an ex vivo expanded, donor-derived, polyclonal population of CD4+ and CD8+ virus-specific human T cells (VSTs) reactive against multiple immunodominant antigens from two or more respiratory viruses, wherein the viruses comprise human metapneumovirus (hMPV) and human parainfluenza virus type 3 (PIV3), wherein the multiple immunodominant antigens from hMPV are fusion (F), nucleoprotein (N), M2-1 protein (M2-1), and matrix protein (M), and wherein the multiple immunodominant antigens from PIV3 comprise matrix protein (M), hemagglutinin-neuraminidase (HN), and nucleoprotein (N).